journal article·2023-03

Protoporphyrin-sensitized degradable bismuth nanoformulations for enhanced sonodynamic oncotherapy

Kang Song, Guobo Chen, Zongyan He, Jing Shen, Jing Ping, Yuhao Li, Lulu Zheng, Yuqing Miao, Dawei Zhang

Acta Biomaterialia· Volume 158
Publisher page

Abstract

Decreasing the scavenging capacity of reactive oxygen species (ROS) and enhancing ROS production are the two principal objectives in the development of novel sonosensitizers for sonodynamic therapy (SDT). Herein, we designed a protoporphyrin-sensitized bismuth-based semiconductor (P-NBOF) as a sonosensitizer to generate ROS and synergistically depleted glutathione for enhanced SDT against tumors. The bismuth-based nanomaterial (NBOF) is a wide-bandgap semiconductor. Sensitization by protoporphyrin made it easier to excite electrons under ultrasonic stimulation, and the energy of the lowest unoccupied electron orbital in protoporphyrin was higher than the conduction-band energy of NBOF. Under ultrasound excitation, the excited electrons in the protoporphyrin were injected into the conduction band of the NBOF, increasing its reducing ability leading to the production of more superoxide anion radicals and also helping to increase the charge separation of protoporphyrin leading to the production of more singlet oxygen. Meanwhile, P-NBOF continuously depleted glutathione, which was not only conducive to breaking the redox balance of the tumor microenvironment to enhance the therapeutic efficacy of SDT, but also promoted its degradation and metabolism. The construction of this P-NBOF sonosensitizer thus provided an effective strategy to enhance SDT for tumors. STATEMENT OF SIGNIFICANCE: To enhance the efficacy of sonodynamic tumor therapy, we developed a degradable protoporphyrin-sensitized bismuth-based nano-semiconductor (P-NBOF) by optimizing the band structure and glutathione-depletion ability. Protoporphyrin in P-NBOF under excitation preferentially generates free electrons, which are then injected into the conduction band of NBOF, improving the reducing ability of NBOF and promoting the separation of electron-hole pairs, thereby enhancing the production capacity of reactive oxygen species. Furthermore, P-NBOF can deplete glutathione, reduce the scavenging of reactive oxygen species, and reactivate and amplify the effect of sonodynamic therapy. The construction of the nanotherapeutic platform provides an option for enhancing sonodynamic therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence Properties of Advanced Materials · Advanced Photocatalysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy10.1002/adma.202003214 ↗
2. Multifunctional sonosensitizers in sonodynamic cancer therapy10.1039/C9CS00648F ↗
3. Nanocatalytic medicine10.1002/adma.201901778 ↗
4. Ultrasound-activated sensitizers and applications10.1002/anie.201906823 ↗
5. Preparation of TiH1.924 nanodots by liquid-phase exfoliation for enhanced sonodynamic cancer therapy10.1038/s41467-020-17485-x ↗
6. Liquid exfoliation of TiN nanodots as novel sonosensitizers for photothermal-enhanced sonodynamic therapy against cancer10.1016/j.nantod.2021.101170 ↗
7. Ultrasound mediated therapy: recent progress and challenges in nanoscience10.1016/j.nantod.2020.100949 ↗
8. Ultrafine titanium monoxide (TiO1+x) nanorods for enhanced sonodynamic therapy10.1021/jacs.9b10228 ↗
9. Scalable yielding of highly stable polyelectrolyte-coated copper sulfide nanoparticles by flash nanoprecipitation for photothermal-chemotherapeutics10.1002/adfm.202100452 ↗
10. A novel Pt–TiO2 heterostructure with oxygen-deficient layer as bilaterally enhanced sonosensitizer for synergistic chemo-sonodynamic cancer therapy10.1002/adfm.201908598 ↗
11. Ultrasmall oxygen-deficient bimetallic oxide MnWOX nanoparticles for depletion of endogenous GSH and enhanced sonodynamic cancer therapy10.1002/adma.201900730 ↗
12. Biodegradable Bismuth-based nano-heterojunction for enhanced sonodynamic oncotherapy through charge separation engineering10.1002/adhm.202102503 ↗
13. 2D piezoelectric Bi2MoO6 nanoribbons for GSH-enhanced sonodynamic therapy10.1002/adma.202106838 ↗
14. Peptide NGR modified TiO2 nanofiber substrate for circulating tumor cells capture10.1007/s42765-020-00040-0 ↗
15. Photocatalytic activity enhanced via surface hybridization10.1002/cey2.66 ↗
16. D–π–A-type triphenylamine dye covalent-functionalized g-C3N4 for highly efficient photocatalytic hydrogen evolution10.1039/D0CY00013B ↗
17. Organic dye for highly efficient solid-state dye-sensitized solar cells10.1002/adma.200401410 ↗
18. Porphyrin-sensitized solar cells with cobalt (II/III)-based redox electrolyte exceed 12 percent efficiency10.1126/science.1209688 ↗
19. Molecular engineering strategies for fabricating efficient porphyrin-based dye-sensitized solar cells10.1039/C9EE04200H ↗
20. Photogenerated-hole-induced rapid elimination of solid tumors by the supramolecular porphyrin photocatalyst10.1093/nsr/nwaa155 ↗
21. Singlet oxygen generation potential of porphyrin-sensitized magnetite nanoparticles: Synthesis, characterization and photocatalytic application10.1016/j.apcatb.2018.03.079 ↗
22. Bismuth sulfide nanorods with retractable zinc protoporphyrin molecules for suppressing innate antioxidant defense system and strengthening phototherapeutic effects10.1002/adma.201806808 ↗
23. Protoporphyrin IX (PpIX)-coated superparamagnetic iron oxide nanoparticle (SPION) nanoclusters for magnetic resonance imaging and photodynamic therapy10.1002/adfm.201707030 ↗
24. Naphthyl-fused π-elongated porphyrins for dye-sensitized TiO2 cells10.1021/jp805122z ↗
25. Piezo-augmented sonosensitizer with strong ultrasound-propelling ability for efficient treatment of osteomyelitis10.1021/acsnano.1c09189 ↗
26. Carbon-dot-supported atomically dispersed gold as a mitochondrial oxidative stress amplifier for cancer treatment10.1038/s41565-019-0373-6 ↗
27. Advanced biotechnology-assisted precise sonodynamic therapy10.1039/D1CS00403D ↗
28. Synthesis of CaCO3-based nanomedicine for enhanced sonodynamic therapy via amplification of tumor oxidative stress10.1016/j.chempr.2020.02.020 ↗
29. Peroxisome inspired hybrid enzyme nanogels for chemodynamic and photodynamic therapy10.1038/s41467-021-25561-z ↗
30. Injectable fiber electronics for tumor treatment10.1007/s42765-021-00099-3 ↗
31. Conquering the hypoxia limitation for photodynamic therapy10.1002/adma.202103978 ↗
32. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy10.1002/adma.202006892 ↗
33. Oxygen-deficient BiOCl combined with L-buthionine-sulfoximine synergistically suppresses tumor growth through enhanced singlet oxygen generation under ultrasound irradiation10.1002/smll.202104550 ↗
34. Nanozyme-incorporated biodegradable bismuth mesoporous radiosensitizer for tumor microenvironment-modulated hypoxic tumor thermoradiotherapy10.1021/acsami.0c18853 ↗
35. Biodegradable BiOCl platform for oxidative stress injury-enhanced chemodynamic/radiation therapy of hypoxic tumors10.1016/j.actbio.2021.05.016 ↗
36. Tumor microenvironment modulation platform based on composite biodegradable bismuth-manganese radiosensitizer for inhibiting radioresistant hypoxic tumors10.1002/smll.202101015 ↗
37. Negative isolation of circulating tumor cells using a microfluidic platform integrated with streptavidin-functionalized PLGA nanofibers10.1007/s42765-021-00075-x ↗
38. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles10.1039/D0CS00031K ↗
39. Systems approaches for unveiling the mechanism of action of bismuth drugs: new medicinal applications beyond helicobacter pylori infection10.1021/acs.accounts.8b00439 ↗
40. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles10.1016/j.biomaterials.2011.05.007 ↗
41. High yield exfoliation of WS2 crystals into 1-2 layer semiconducting nanosheets and efficient photocatalytic hydrogen evolution from WS2/CdS nanorod composites10.1021/acsami.7b15614 ↗
42. Nanostructured 2D diporphyrin honeycomb film: photoelectrochemistry, photodegradation, and antibacterial activity10.1021/acsami.5b03254 ↗
43. Protoporphyrin IX functionalized α-Fe2O3 for enhanced photocatalytic and antimicrobial activity under sunlight10.1142/S1793604719500796 ↗
44. Ultraslow recombination in AOT-capped TiO2 nanoparticles sensitized by protoporphyrin IX10.1039/C4DT01926A ↗
45. Inorganic nanomaterials with rapid clearance for biomedical applications10.1039/D0CS00461H ↗
46. Degradable mesoporous semimetal antimony nanospheres for near-infrared II multimodal theranostics10.1038/s41467-021-27835-y ↗
47. An ultrasound activated vesicle of Janus Au-MnO nanoparticles for promoted tumor penetration and sono-chemodynamic therapy of orthotopic liver cancer10.1002/anie.201912768 ↗
48. GSH-depleted nanozymes with hyperthermia-enhanced dual enzyme-mimic activities for tumor nanocatalytic therapy10.1002/adma.202002439 ↗
49. Tumor microenvironment stimuli-responsive fluorescence imaging and synergistic cancer therapy by carbon-Dot-Cu2+ nanoassemblies10.1002/anie.202007786 ↗
50. An acidity-unlocked magnetic nanoplatform enables self-boosting ROS generation through upregulation of lactate for imaging-guided highly specific chemodynamic therapy10.1002/anie.202014415 ↗
51. A pH/Ultrasound dual-response biomimetic nanoplatform for nitric oxide gas-sonodynamic combined therapy and repeated ultrasound for relieving hypoxia10.1016/j.biomaterials.2019.119636 ↗
52. Functional electrospun fibers for local therapy of cancer10.1007/s42765-020-00053-9 ↗
53. A hybrid semiconducting organosilica-based O2 nanoeconomizer for on-demand synergistic photothermally boosted radiotherapy10.1038/s41467-020-20860-3 ↗
54. An NIR discrete metallacycle constructed from perylene bisimide and tetraphenylethylene fluorophores for imaging-guided cancer radio-chemotherapy10.1002/adma.202106388 ↗